Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.

2.50
Hdl Handle:
http://hdl.handle.net/10033/621040
Title:
Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
Authors:
Karo, Basel; Krause, Gerard ( 0000-0003-3328-8808 ) ; Castell, Stefanie; Kollan, Christian; Hamouda, Osamah; Haas, Walter
Abstract:
Understanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-treated HIV-infected patients developing TB compared to those who remained free of TB.
Citation:
Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. 2017, 17 (1):517 BMC Infect. Dis.
Journal:
BMC infectious diseases
Issue Date:
25-Jul-2017
URI:
http://hdl.handle.net/10033/621040
DOI:
10.1186/s12879-017-2627-y
PubMed ID:
28743248
Type:
Article
Language:
en
ISSN:
1471-2334
Appears in Collections:
Publications of the department of epidemiology (EPID)

Full metadata record

DC FieldValue Language
dc.contributor.authorKaro, Baselen
dc.contributor.authorKrause, Gerarden
dc.contributor.authorCastell, Stefanieen
dc.contributor.authorKollan, Christianen
dc.contributor.authorHamouda, Osamahen
dc.contributor.authorHaas, Walteren
dc.date.accessioned2017-08-03T14:32:51Z-
dc.date.available2017-08-03T14:32:51Z-
dc.date.issued2017-07-25-
dc.identifier.citationImmunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. 2017, 17 (1):517 BMC Infect. Dis.en
dc.identifier.issn1471-2334-
dc.identifier.pmid28743248-
dc.identifier.doi10.1186/s12879-017-2627-y-
dc.identifier.urihttp://hdl.handle.net/10033/621040-
dc.description.abstractUnderstanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-treated HIV-infected patients developing TB compared to those who remained free of TB.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleImmunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.en
dc.typeArticleen
dc.identifier.journalBMC infectious diseasesen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.